Literature DB >> 12637438

The natural history of symptomatic osteonecrosis in adults with sickle-cell disease.

P Hernigou1, D Bachir, F Galacteros.   

Abstract

BACKGROUND: Adult patients with sickle-cell disease are at risk for the development of osteonecrosis of the hip. However, there is little information in the literature about the rate of progression of osteonecrosis once symptoms begin. The purpose of this study was to evaluate the natural history of the symptomatic hip in adult patients with osteonecrosis and sickle-cell disease.
METHODS: Ninety-two symptomatic hips in sixty-four consecutive adult patients with sickle-cell disease were initially evaluated between 1980 and 1987. Sixty symptomatic hips had radiographic evidence of osteonecrosis at the initial evaluation: forty-three were classified as stage II; two, as stage III; and fifteen, as stage IV, according to the system of Steinberg et al. The other thirty-two hips had lesions (stage I) that were evident only on magnetic resonance imaging. All patients were evaluated after a mean duration of follow-up of seventeen years.
RESULTS: Of the seventy-five hips without collapse of the femoral head at the initial evaluation, sixty-five demonstrated collapse within five years after the diagnosis. The average time between the diagnosis and collapse was forty-two months for stage-I hips and thirty months for stage-II hips. At the most recent follow-up examination, ninety hips had had collapse of the femoral head and eighty-eight of the ninety-two hips had had surgery because of intractable pain.
CONCLUSIONS: Symptomatic osteonecrosis of the hip in sickle-cell disease has a high likelihood of leading to femoral head collapse, necessitating surgical intervention. When osteonecrosis develops, the deterioration is rapid and, in most patients, operative intervention is necessary because of intractable pain. LEVEL OF EVIDENCE: Prognostic study, Level II-1 (retrospective study). See Instructions to Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2003        PMID: 12637438     DOI: 10.2106/00004623-200303000-00016

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  32 in total

Review 1.  Complications in brief: Osteotomy for lower extremity malalignment.

Authors:  Loukas Koyonos; Nick Slenker; Steven Cohen
Journal:  Clin Orthop Relat Res       Date:  2012-12       Impact factor: 4.176

2.  CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.

Authors:  Cody C Wyles; Christopher R Paradise; Matthew T Houdek; Susan L Slager; Andre Terzic; Atta Behfar; Andre J van Wijnen; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2019-08       Impact factor: 4.176

3.  Core decompression with autologous bone marrow aspirate injection in humeral head osteonecrosis in adults with sickle cell disease.

Authors:  Gilles Guerin; Anoosha Habibi; Philippe Hernigou; Sebastien Zilber
Journal:  Int Orthop       Date:  2021-02-05       Impact factor: 3.075

4.  Treatment of osteonecrosis of the femoral head with vascularized bone grafting.

Authors:  Patrick D Millikan; Vasili Karas; Samuel S Wellman
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

5.  The safety and efficacy of combined autologous concentrated bone marrow grafting and low-intensity pulsed ultrasound in the treatment of osteonecrosis of the femoral head.

Authors:  Hajime Mishima; Hisashi Sugaya; Tomokazu Yoshioka; Katsuya Aoto; Hiroshi Wada; Hiroshi Akaogi; Naoyuki Ochiai
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-02-27

6.  Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.

Authors:  Oyebimpe Adesina; Ann Brunson; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2017-07-11

7.  The staged management of gleno-humeral joint osteonecrosis in patients with haematological-induced disease-a cohort review.

Authors:  Toby J Colegate-Stone; Saurabh Aggarwal; Karthik Karuppaiah; Adel Tavakkolizadeh; Joydeep Sinha; Ines Lh Reichert
Journal:  Int Orthop       Date:  2018-05-11       Impact factor: 3.075

Review 8.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

9.  Rapid resolution of femoral head osteonecrosis after rotational acetabular osteotomy.

Authors:  Masahiko Nozawa; Keiji Matsuda; Katsuhiko Maezawa; Sungon Kim; Kouichi Maeda; Takashi Ikegami; Reiko Kubota; Kentaro Hayashi; Masataka Nagayama; Haruka Kaneko
Journal:  J Orthop Traumatol       Date:  2008-10-25

10.  Multifocal joint osteonecrosis in sickle cell disease.

Authors:  Charles Henri Flouzat-Lachaniete; Xavier Roussignol; Alexandre Poignard; Martin Mukisi Mukasa; Olivier Manicom; Philippe Hernigou
Journal:  Open Orthop J       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.